Cargando…

Opportunities for Antigen Discovery in Metastatic Breast Cancer

Immune checkpoint inhibitor-based immunotherapy (ICI) of breast cancer is currently efficacious in a fraction of triple negative breast cancers (TNBC) as these cancers generally carry high tumor mutation burden (TMB) and show increased tumor infiltration by CD8(+) T cells. However, most estrogen rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Ashwani K., Nemeth, Michael, Wang, Jianmin, Wu, Yun, Gandhi, Shipra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661635/
https://www.ncbi.nlm.nih.gov/pubmed/33193348
http://dx.doi.org/10.3389/fimmu.2020.570049

Ejemplares similares